Seroprevalence of severe acute respiratory syndrome coronavirus 2 immunoglobulin G antibodies among health-care workers prior and after 4–6 weeks of coronavirus disease vaccine administration at tertiary care center of southwest Bihar, India

AIM: Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an ongoing global health emergency. To control the spread, a mass vaccination program is initiated. Antibody titer after vaccination can be a better marker to monitor immunological resp...

Full description

Bibliographic Details
Main Authors: Mukesh Kumar, Richa Singh, Abhishek Kamendu, Amit Kumar Singh, Jyoti Sangwan
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Indian Journal of Health Sciences and Biomedical Research KLEU
Subjects:
Online Access:http://www.ijournalhs.org/article.asp?issn=2542-6214;year=2022;volume=15;issue=3;spage=256;epage=260;aulast=Kumar
_version_ 1798021919708020736
author Mukesh Kumar
Richa Singh
Abhishek Kamendu
Amit Kumar Singh
Jyoti Sangwan
author_facet Mukesh Kumar
Richa Singh
Abhishek Kamendu
Amit Kumar Singh
Jyoti Sangwan
author_sort Mukesh Kumar
collection DOAJ
description AIM: Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an ongoing global health emergency. To control the spread, a mass vaccination program is initiated. Antibody titer after vaccination can be a better marker to monitor immunological response. MATERIALS AND METHODS: The study was carried out at the Department of Microbiology, Narayan Medical College and Hospital, Jamuhar Sasaram, southwest Bihar, considering the sample size, type, and collection. First, antibody was tested before vaccination and second antibody value after 28 days of the first dose of COVID vaccine among the health-care workers and housekeeping staff. RESULTS: A total of 251 subjects were administered with vaccination (Covishield) to check the immunoglobulin g (IgG) responses. The concentration of the SARS-CoV-2 IgG antibody in female patients tended to be higher than in male patients. CONCLUSION: There is a difference in antibody positivity among males and females. Most of the participants had IgG positivity, because of their profession, vaccination boosted percentage positivity in both males and females. Females have more IgG levels compared to males. Hence, recommend that separate guidelines can be made between males and females for vaccination dosages.
first_indexed 2024-04-11T17:21:23Z
format Article
id doaj.art-a85ae533a8ae41af915afeb684e003ea
institution Directory Open Access Journal
issn 2542-6214
2542-6222
language English
last_indexed 2024-04-11T17:21:23Z
publishDate 2022-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Indian Journal of Health Sciences and Biomedical Research KLEU
spelling doaj.art-a85ae533a8ae41af915afeb684e003ea2022-12-22T04:12:29ZengWolters Kluwer Medknow PublicationsIndian Journal of Health Sciences and Biomedical Research KLEU2542-62142542-62222022-01-0115325626010.4103/kleuhsj.kleuhsj_179_21Seroprevalence of severe acute respiratory syndrome coronavirus 2 immunoglobulin G antibodies among health-care workers prior and after 4–6 weeks of coronavirus disease vaccine administration at tertiary care center of southwest Bihar, IndiaMukesh KumarRicha SinghAbhishek KamenduAmit Kumar SinghJyoti SangwanAIM: Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an ongoing global health emergency. To control the spread, a mass vaccination program is initiated. Antibody titer after vaccination can be a better marker to monitor immunological response. MATERIALS AND METHODS: The study was carried out at the Department of Microbiology, Narayan Medical College and Hospital, Jamuhar Sasaram, southwest Bihar, considering the sample size, type, and collection. First, antibody was tested before vaccination and second antibody value after 28 days of the first dose of COVID vaccine among the health-care workers and housekeeping staff. RESULTS: A total of 251 subjects were administered with vaccination (Covishield) to check the immunoglobulin g (IgG) responses. The concentration of the SARS-CoV-2 IgG antibody in female patients tended to be higher than in male patients. CONCLUSION: There is a difference in antibody positivity among males and females. Most of the participants had IgG positivity, because of their profession, vaccination boosted percentage positivity in both males and females. Females have more IgG levels compared to males. Hence, recommend that separate guidelines can be made between males and females for vaccination dosages.http://www.ijournalhs.org/article.asp?issn=2542-6214;year=2022;volume=15;issue=3;spage=256;epage=260;aulast=Kumar2019 novel coronaviruscoronavirus disease 2019novel coronavirus pneumoniasevere acute respiratory syndrome coronavirus 2
spellingShingle Mukesh Kumar
Richa Singh
Abhishek Kamendu
Amit Kumar Singh
Jyoti Sangwan
Seroprevalence of severe acute respiratory syndrome coronavirus 2 immunoglobulin G antibodies among health-care workers prior and after 4–6 weeks of coronavirus disease vaccine administration at tertiary care center of southwest Bihar, India
Indian Journal of Health Sciences and Biomedical Research KLEU
2019 novel coronavirus
coronavirus disease 2019
novel coronavirus pneumonia
severe acute respiratory syndrome coronavirus 2
title Seroprevalence of severe acute respiratory syndrome coronavirus 2 immunoglobulin G antibodies among health-care workers prior and after 4–6 weeks of coronavirus disease vaccine administration at tertiary care center of southwest Bihar, India
title_full Seroprevalence of severe acute respiratory syndrome coronavirus 2 immunoglobulin G antibodies among health-care workers prior and after 4–6 weeks of coronavirus disease vaccine administration at tertiary care center of southwest Bihar, India
title_fullStr Seroprevalence of severe acute respiratory syndrome coronavirus 2 immunoglobulin G antibodies among health-care workers prior and after 4–6 weeks of coronavirus disease vaccine administration at tertiary care center of southwest Bihar, India
title_full_unstemmed Seroprevalence of severe acute respiratory syndrome coronavirus 2 immunoglobulin G antibodies among health-care workers prior and after 4–6 weeks of coronavirus disease vaccine administration at tertiary care center of southwest Bihar, India
title_short Seroprevalence of severe acute respiratory syndrome coronavirus 2 immunoglobulin G antibodies among health-care workers prior and after 4–6 weeks of coronavirus disease vaccine administration at tertiary care center of southwest Bihar, India
title_sort seroprevalence of severe acute respiratory syndrome coronavirus 2 immunoglobulin g antibodies among health care workers prior and after 4 6 weeks of coronavirus disease vaccine administration at tertiary care center of southwest bihar india
topic 2019 novel coronavirus
coronavirus disease 2019
novel coronavirus pneumonia
severe acute respiratory syndrome coronavirus 2
url http://www.ijournalhs.org/article.asp?issn=2542-6214;year=2022;volume=15;issue=3;spage=256;epage=260;aulast=Kumar
work_keys_str_mv AT mukeshkumar seroprevalenceofsevereacuterespiratorysyndromecoronavirus2immunoglobulingantibodiesamonghealthcareworkerspriorandafter46weeksofcoronavirusdiseasevaccineadministrationattertiarycarecenterofsouthwestbiharindia
AT richasingh seroprevalenceofsevereacuterespiratorysyndromecoronavirus2immunoglobulingantibodiesamonghealthcareworkerspriorandafter46weeksofcoronavirusdiseasevaccineadministrationattertiarycarecenterofsouthwestbiharindia
AT abhishekkamendu seroprevalenceofsevereacuterespiratorysyndromecoronavirus2immunoglobulingantibodiesamonghealthcareworkerspriorandafter46weeksofcoronavirusdiseasevaccineadministrationattertiarycarecenterofsouthwestbiharindia
AT amitkumarsingh seroprevalenceofsevereacuterespiratorysyndromecoronavirus2immunoglobulingantibodiesamonghealthcareworkerspriorandafter46weeksofcoronavirusdiseasevaccineadministrationattertiarycarecenterofsouthwestbiharindia
AT jyotisangwan seroprevalenceofsevereacuterespiratorysyndromecoronavirus2immunoglobulingantibodiesamonghealthcareworkerspriorandafter46weeksofcoronavirusdiseasevaccineadministrationattertiarycarecenterofsouthwestbiharindia